Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals SafiledCriticalGlenmark Pharmaceuticals Sa
Publication of MY152686ApublicationCriticalpatent/MY152686A/en
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur
(AREA)
Abstract
THE PRESENT INVENTION IS RELATED TO NOVEL THIENOPYRIMIDINEDIONE DERIVATIVES AS TRPA (TRANSIENT RECEPTOR POTENTIAL SUBFAMILY A) MODULATORS. IN PARTICULAR, COMPOUNDS DESCRIBED HEREIN ARE USEFUL FOR TREATING OR PREVENTING DISEASES, CONDITIONS AND/OR DISORDERS MODULATED BY TRPA1 (TRANSIENT RECEPTOR POTENTIAL SUBFAMILY A, MEMBER 1). ALSO PROVIDED HEREIN ARE PROCESSES FOR PREPARING COMPOUNDS DESCRIBED HEREIN, INTERMEDIATES USED IN THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS FOR TREATING OR PREVENTING DISEASES, CONDITIONS AND/OR DISORDERS MODULATED BY TRPA1.
MYPI20110045182009-03-232010-03-23Thienopyrimidinedione derivative as trpa1 modulators
MY152686A
(en)